Gut Microbiome is Associated with the Clinical Response to Anti-PD1 Based Immunotherapy in Hepatobiliary Cancers by https://padlet.com/alexvndra12/x6mj7s5nah3oepjl Mao et al. 2021 en-us 2023-05-24 01:04:21 UTC 2023-06-09 16:41:37 UTC hello@padlet.com Gut microbiome composition and clinical response amandahexinru https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619478557 2023-06-09 16:37:05 UTC https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619478557 Differentially enriched taxa and survival benefits amandahexinru https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619478945 2023-06-09 16:37:43 UTC https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619478945 Enriched metabolic pathways amandahexinru https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619480657 2023-06-09 16:39:45 UTC https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619480657 Gut microbiome and immunotherapy-related adverse events amandahexinru https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619480955 2023-06-09 16:40:14 UTC https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619480955 Clinical factors affect gut microbiome enrichment amandahexinru https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619481945 2023-06-09 16:41:21 UTC https://padlet.com/alexvndra12/x6mj7s5nah3oepjl/wish/2619481945